U.S. Markets open in 7 hrs 49 mins

At €27.14, Is It Time To Put Corbion N.V. (AMS:CRBN) On Your Watch List?

Simply Wall St

Corbion N.V. (AMS:CRBN), which is in the chemicals business, and is based in Netherlands, received a lot of attention from a substantial price movement on the ENXTAM over the last few months, increasing to €29.96 at one point, and dropping to the lows of €24.84. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Corbion's current trading price of €27.14 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Corbion’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

View our latest analysis for Corbion

What's the opportunity in Corbion?

According to my valuation model, Corbion seems to be fairly priced at around 13% below my intrinsic value, which means if you buy Corbion today, you’d be paying a fair price for it. And if you believe the company’s true value is €31.24, then there isn’t much room for the share price grow beyond what it’s currently trading. What's more, Corbion’s share price may be more stable over time (relative to the market), as indicated by its low beta.

What does the future of Corbion look like?

ENXTAM:CRBN Past and Future Earnings, September 7th 2019

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. Corbion’s earnings over the next few years are expected to increase by 82%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.

What this means for you:

Are you a shareholder? It seems like the market has already priced in CRBN’s positive outlook, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at the stock? Will you have enough conviction to buy should the price fluctuates below the true value?

Are you a potential investor? If you’ve been keeping tabs on CRBN, now may not be the most optimal time to buy, given it is trading around its fair value. However, the positive outlook is encouraging for the company, which means it’s worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on Corbion. You can find everything you need to know about Corbion in the latest infographic research report. If you are no longer interested in Corbion, you can use our free platform to see my list of over 50 other stocks with a high growth potential.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.